Focus Partners Advisor Solutions LLC Purchases New Holdings in The Cooper Companies, Inc. $COO

Focus Partners Advisor Solutions LLC bought a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 10,925 shares of the medical device company’s stock, valued at approximately $783,000.

Several other large investors have also recently made changes to their positions in the business. State of Wyoming bought a new position in Cooper Companies during the 2nd quarter valued at approximately $420,000. Avalon Trust Co bought a new stake in Cooper Companies in the second quarter worth $25,000. Bridgewater Advisors Inc. purchased a new stake in shares of Cooper Companies in the second quarter worth $407,000. Tema ETFs LLC grew its stake in shares of Cooper Companies by 42.4% in the second quarter. Tema ETFs LLC now owns 4,249 shares of the medical device company’s stock worth $305,000 after acquiring an additional 1,266 shares during the last quarter. Finally, Handelsbanken Fonder AB increased its holdings in shares of Cooper Companies by 1.1% during the second quarter. Handelsbanken Fonder AB now owns 74,834 shares of the medical device company’s stock valued at $5,366,000 after acquiring an additional 832 shares in the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Trading Down 1.4%

Shares of COO stock opened at $75.10 on Tuesday. The company has a current ratio of 1.27, a quick ratio of 0.78 and a debt-to-equity ratio of 0.23. The Cooper Companies, Inc. has a 12-month low of $58.89 and a 12-month high of $89.83. The stock has a market capitalization of $14.65 billion, a P/E ratio of 63.64, a P/E/G ratio of 1.99 and a beta of 0.83. The firm’s 50 day moving average is $71.27 and its 200 day moving average is $71.22.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Research analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. Citigroup reiterated a “neutral” rating and issued a $80.00 target price (up from $76.00) on shares of Cooper Companies in a research note on Thursday. The Goldman Sachs Group set a $61.00 price target on shares of Cooper Companies in a research report on Wednesday, May 27th. Robert W. Baird decreased their price objective on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, June 5th. Wall Street Zen upgraded Cooper Companies from a “hold” rating to a “buy” rating in a research note on Sunday, June 21st. Finally, KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $81.64.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.